$9.37
N/A
Last update: Nov 10, 4:00 PM
InnovAge Holding Corp
INNVNASDAQ
InnovAge rose 72.9% from $5.42 to $9.37, ahead of the S&P 500's +9.8%. Its worst day was Sep 23 (−15.5%), and its low came Dec 8 at $4.79.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
InnovAge shares rose 12.5%, while the S&P 500 fell 0.8%.
+12.5% · S&P 500 −0.8%
InnovAge closed at its lowest level of the year, 11.6% below where the year started.
−4.8% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $0.08 beat the $0.04 estimate on $239.7M revenue (est. $228.3M); FY revenue guidance of $925.0M–$950.0M against the $930.3M consensus.
+37.5%, the year's best day · S&P 500 −0.5%
InnovAge shares rose 11.7%, while the S&P 500 rose 0.7%.
+11.7% · S&P 500 +0.7%
EPS of $-0.22 missed the $0.05 estimate on $251.9M revenue (est. $234.3M); FY revenue guidance of $950.0M–$975.0M against the $944.5M consensus.
+2.0% · S&P 500 +1.4%
InnovAge closed at its highest level of the year, 123.4% above where the year started.
+1.0% · S&P 500 +0.9%
EPS of $0.06 missed the $0.08 estimate on $262.0M revenue (est. $238.3M); FY revenue guidance of $1.1B–$1.1B against the $1.0B consensus.
+4.8% · S&P 500 −0.5%
InnovAge shares fell 15.5%, while the S&P 500 fell 0.7%.
−15.5%, the year's worst day, on 7M shares, the year's heaviest volume · S&P 500 −0.7%
EPS of $0.14 beat the $0.09 estimate on $236.1M revenue (est. $255.7M); FY revenue guidance of $1.1B–$1.1B against the $1.1B consensus.
+10.6% · S&P 500 +1.7%
Where it ended: a close of $9.37 on Nov 10, 2026. Up next: Q2 2027 earnings on Feb 2, 2027 (EPS est. $0.10, revenue est. $261.1M).
Nothing in the past 12 months.
All INNV dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INNV and SPY from Benzinga historical bars. Not investment advice.
